PT  - JOURNAL ARTICLE
ED  - Nakao, Kazuwa
TI  - Candesartan and Amlodipine: Effect on the Incidence of Cardiovascular Events and New-Onset Diabetes
DP  - 2010 Nov 01
TA  - MD Conference Express
PG  - 12--12
VI  - 10
IP  - 5
4099  - http://mdc.sagepub.com/content/10/5/12.1.short
4100  - http://mdc.sagepub.com/content/10/5/12.1.full
AB  - The 3-year extension of the Candesartan Antihypertensive Survival Evaluation in Japan [CASE-J] Study demonstrated comparable efficacy of the angiotensin receptor blocker candesartan and the calcium channel blocker amlodipine on the incidence of cardiovascular events in high-risk hypertensive Japanese patients. As observed in the earlier phase of the study, cadesartan exhibited sustained superiority over amlodipine with regards to reduction in new-onset diabetes throughout the 3-year extended follow up.